Lanzi C - Search Results

1

Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1.

Lanzi C, Cassinelli G, Cuccuru G, Zaffaroni N, Supino R, Vignati S, Zanchi C, Yamamoto M, Zunino F. Lanzi C, et al. Cell Mol Life Sci. 2003 Jul;60(7):1449-59. doi: 10.1007/s00018-003-2381-8. Cell Mol Life Sci. 2003. PMID: 12943231 Free PMC article.

2

Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.

Lanzi C, Borrello MG, Bongarzone I, Migliazza A, Fusco A, Grieco M, Santoro M, Gambetta RA, Zunino F, Della Porta G, et al. Lanzi C, et al. Oncogene. 1992 Nov;7(11):2189-94. Oncogene. 1992. PMID: 1437145

3

TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.

Greco A, Pierotti MA, Bongarzone I, Pagliardini S, Lanzi C, Della Porta G. Greco A, et al. Among authors: lanzi c. Oncogene. 1992 Feb;7(2):237-42. Oncogene. 1992. PMID: 1532241

4

Protein kinase C activation by anthracyclines in Swiss 3T3 cells.

Lanzi C, Gambetta RA, Perego P, Banfi P, Franzi A, Guazzoni L, Zunino F. Lanzi C, et al. Int J Cancer. 1991 Jan 2;47(1):136-42. doi: 10.1002/ijc.2910470124. Int J Cancer. 1991. PMID: 1845961

5

Protein kinase C activation and lipid peroxidation by doxorubicin analogues.

Gambetta RA, Banfi P, Lanzi C, Franzi A, Zunino F. Gambetta RA, et al. Among authors: lanzi c. Tumori. 1989 Aug 31;75(4):358-61. doi: 10.1177/030089168907500411. Tumori. 1989. PMID: 2815343

6

A cell and mechanism-based approach for the selection of EGF receptor inhibitors.

Lanzi C, Pensa T, Cassinis M, Corti C, Gambetta RA, Pratesi G, Menta E, Ardini E, Zunino F. Lanzi C, et al. Anticancer Drug Des. 1997 Sep;12(6):515-24. Anticancer Drug Des. 1997. PMID: 9311559 No abstract available.

7

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance.

Lanzi C, Perego P, Supino R, Romanelli S, Pensa T, Carenini N, Viano I, Colangelo D, Leone R, Apostoli P, Cassinelli G, Gambetta RA, Zunino F. Lanzi C, et al. Biochem Pharmacol. 1998 Apr 15;55(8):1247-54. doi: 10.1016/s0006-2952(97)00599-6. Biochem Pharmacol. 1998. PMID: 9719480

8

Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative.

Lanzi C, Cassinelli G, Pensa T, Cassinis M, Gambetta RA, Borrello MG, Menta E, Pierotti MA, Zunino F. Lanzi C, et al. Int J Cancer. 2000 Feb 1;85(3):384-90. Int J Cancer. 2000. PMID: 10652431

9

Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.

Cassinelli G, Lanzi C, Pensa T, Gambetta RA, Nasini G, Cuccuru G, Cassinis M, Pratesi G, Polizzi D, Tortoreto M, Zunino F. Cassinelli G, et al. Among authors: lanzi c. Biochem Pharmacol. 2000 Jun 15;59(12):1539-47. doi: 10.1016/s0006-2952(00)00278-1. Biochem Pharmacol. 2000. PMID: 10799650

10

Structure elucidation of clavilactone D: an inhibitor of protein tyrosine kinases.

Merlini L, Nasini G, Scaglioni L, Cassinelli G, Lanzi C. Merlini L, et al. Among authors: lanzi c. Phytochemistry. 2000 Apr;53(8):1039-41. doi: 10.1016/s0031-9422(99)00506-3. Phytochemistry. 2000. PMID: 10820827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters